Volume 11, Issue 2 (Iranian Quarterly Journal of Breast Disease 2018)                   ijbd 2018, 11(2): 7-15 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khanbabayi Gol M, Arefi N, Jafari M, Farzin H, Aghamohammadi D. Prevalence of Port-Related Infections and Their Predisposing Factors in Women with Breast Cancer under Chemotherapy. ijbd. 2018; 11 (2) :7-15
URL: http://ijbd.ir/article-1-682-en.html
, davoodaghamohammadi@yahoo.com
Abstract:   (2896 Views)
Abstract
Introduction: Awareness of the prevalence of chemotherapy port infections and the underlying factors in cancer patients is absolutely necessary, providing us with methods to help eliminate the infection in these patients the aim of this study was to determine the prevalence of port-related infections and the associated factors in women with breast cancer under chemotherapy.
Methods: A total of 73 patients undergoing chemotherapy for treatment of breast cancer were screened for signs of infection following port insertion in the subclavian area. After confirmation of the symptoms of infection, samples were sent to two laboratories for diagnosis of infection. A P value of < .05 was considered significant.
Results: Ten percent of the patients with clinical symptoms of infection were diagnosed with infection in laboratory tests. There were statistically significant differences in weight, age, the number of chemotherapy sessions, the duration of port placement, and the duration of hospitalization following port implantation between patients with infection and patients with no infection.
Conclusion: Port-related infection in patients whit breast cancer can compromise the treatment process. Therefore, achieving better treatment outcomes requires considering the duration of port implantation and use, as well as paying attention to the clinical symptoms of infection and the underlying factors.
 
Full-Text [PDF 141 kb]   (4920 Downloads)    
Port-related infection in patients whit breast cancer can compromise the treatment process. Therefore, achieving better treatment outcomes requires considering the duration of port implantation and use, as well as paying attention to the clinical symptoms of infection and the underlying factors.

Type of Study: Research | Subject: Breast
Received: 2018/06/30 | Accepted: 2018/08/29 | Published: 2018/09/22

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Iranian Quarterly Journal of Breast Disease

Designed & Developed by : Yektaweb